NDA 17-037/S-158
Page 30
Maintenance of Patency of Intravenous Devices
To prevent clot formation in a heparin lock set or central venous catheter
following its proper insertion,
Preservative-Free Heparin Lock Flush Solution, USP is injected via the injection hub in a quantity
sufficient to fill the entire device. This solution should be replaced each time the device is used.
Aspirate before administering any solution via the device in order to confirm
patency and location of
needle or catheter tip. If the drug to be administered is incompatible with heparin, the entire device
should be flushed with normal saline before and after the medication
is administered; following the
second saline flush, Preservative-Free
Heparin Lock Flush Solution, USP may be reinstilled into the
device. The device manufacturer's instructions should be consulted for specifics concerning its use.
Usually this dilute heparin solution will maintain anticoagulation within the device for up to 4 hours.
NOTE:
Since repeated injections of small doses of heparin can alter tests for activated partial
thromboplastin time (APTT), a baseline value for APTT should be obtained
prior to insertion of an
intravenous device.
Withdrawal of Blood Samples
Preservative-Free Heparin Lock Flush Solution, USP may also be used after
each withdrawal of blood
for laboratory tests. When heparin would interfere with or alter the results of blood tests, the heparin
solution should be cleared from the device by aspirating and discarding it before withdrawing the
blood sample.
HOW SUPPLIED
HEP-LOCK U/P (Preservative-Free Heparin Lock Flush Solution, USP)
10 USP units/mL
1 mL DOSETTE vials packaged in 25s (NDC
0641-0272-25)
100 USP units/mL
1 mL DOSETTE vials packaged in 25s (NDC
0641-0273-25)
Dostları ilə paylaş: